UHRF2 and breast cancer: It has been reported that UHRF2 could lead to G0/G1 phase arrest of cell cycle through ubiquitinating cyclins D1 and E1 and served as a candidate tumor suppressor in breast cancer and lung cancer 4, 34, 35.